Pritesh Shah, Chief Commercial Officer at NovoCure Ltd (NVCR), sold 7,434 shares at $76.41 ($570K) on 2020-08-03, disclosed to the SEC on 2020-08-05.
Open-market sale of $570k NVCR by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $76.41 | 1,669 | $128K | 22.4% |
| 2 | $76.41 | 1,669 | $128K | 22.4% |
| 3 | $76.81 | 2,048 | $157K | 27.6% |
| 4 | $76.81 | 2,048 | $157K | 27.6% |
| Total | $76.63 avg | 7,434 | $570K | 100% |
| Filing → |
| NVCR | SELL | 2023-03-07 | $3.3M | — | Filing → |
| NVCR | SELL | 2023-03-06 | $141K | — | Filing → |
| NVCR | SELL | 2023-03-02 | $294K | — | Filing → |